Surfacide

Surfacide Introducing our FDA Approved Helios+ UV-C System for Whole Room Microbial Reduction.

Surfacide is a leading UV-C technology and infection prevention company creating cleaner, safer environments through scientifically proven, hospital-grade solutions.

While we appreciate the communication from APIC to attendees on the trade show floor regarding Whole Room Microbial Redu...
06/15/2026

While we appreciate the communication from APIC to attendees on the trade show floor regarding Whole Room Microbial Reduction Devices, this category has been clearly defined by the FDA since 2023.

It is increasingly concerning to see manufacturers exhibit and market at national infection prevention conferences in the US trying to sidestep this regulatory requirement, whether by citing EPA registration or suggesting their devices avoid medical device surfaces.

In practice, non-critical medical device surfaces encompass the entire patient environment, including bedrails, IV poles, tray tables, nurse call buttons, sinks, toilets, door handles, workstations, and more. There is no alternative pathway for these claims in healthcare settings.

Find us at booth 1617 and learn more about the FDA’s QXJ category.

 

Live from APIC 2026.You’ll see a lot of UV technology on the show floor this week. But only two exhibitors at APIC 2026 ...
06/15/2026

Live from APIC 2026.

You’ll see a lot of UV technology on the show floor this week. But only two exhibitors at APIC 2026 are currently FDA authorized for Whole Room Microbial Reduction under the FDA’s QXJ classification.

Today, Surfacide and Xenex are jointly reinforcing an important message for healthcare leaders:

FDA Authorization for Whole Room Microbial Reduction is NOT OPTIONAL for UV used in the presence of non-critical medical device surfaces.

Stop by our booths to learn more about:

FDA’s Whole Room Microbial Reduction category

Why authorization matters

What Infection Preventionists should know when evaluating UV technologies

Surfacide and Xenex may compete in the marketplace, but we share a commitment to ensuring the healthcare community is not left with the impression that FDA authorization for UV technologies used in healthcare environments is optional, unnecessary, or interchangeable with EPA oversight for this intended use.

Find us at APIC: Surfacide Booth 1617 Xenex Booth 2203

 

We may compete in the marketplace. But on one issue, we agree:FDA Authorization for Whole Room Microbial Reduction is NO...
06/11/2026

We may compete in the marketplace. But on one issue, we agree:

FDA Authorization for Whole Room Microbial Reduction is NOT OPTIONAL for UV used in the presence of non-critical medical device surfaces.

At APIC 2026, Surfacide and Xenex are proud to support greater awareness of the FDA’s QXJ Whole Room Microbial Reduction device classification and what it means for healthcare organizations focused on patient safety, compliance, and evidence-based technology decisions.

All UV technologies marketed for microbial reduction in healthcare settings where non-critical medical device surfaces are present are required to have FDA authorization. Yet at the nation’s largest conference for Infection Preventionists, currently only two exhibitors have achieved this.

Find us at APIC:
Surfacide Booth 1617 Xenex Booth 2203

Healthcare environments aren’t one-size-fits-all.Your UV-C solution shouldn’t be either.Some spaces may be best served b...
06/04/2026

Healthcare environments aren’t one-size-fits-all.

Your UV-C solution shouldn’t be either.

Some spaces may be best served by a single emitter. Others benefit from broader coverage and greater operational efficiency.

That’s why Helios+ was designed to be deployed with one, two, or three emitters, depending on the environment's needs.

The Power of One.
The Power of Three.

One flexible system designed to adapt to your workflow - not the other way around.

Because flexibility isn’t complexity.

It’s having the right solution for the room, the workflow, and the outcome.

We’re headed to Nashville this month! 🎸The Surfacide team is excited to be at APIC 2026, June 15–17, and we invite you t...
06/01/2026

We’re headed to Nashville this month! 🎸

The Surfacide team is excited to be at APIC 2026, June 15–17, and we invite you to stop by Booth #1617 to learn more about our FDA-authorized Helios+ UV-C System for Whole Room Microbial Reduction.

We’ll be discussing the latest science behind UV-C technology and showcasing the flexibility of the Helios+ system. Whether you need a single emitter solution or whole room coverage in a single cycle with our triple emitter configuration, Helios+ is designed to fit your workflow. We’ll also be sharing why evidence and FDA authorization both play an important role in healthcare decision making.

Stop by, we’d love to connect.

📍 Booth #1617 | APIC 2026 | June 15–17 | Nashville

Healthcare doesn’t need more heroics.It needs systems that don’t fail.Standard cleaning protocols are essential, but on ...
04/16/2026

Healthcare doesn’t need more heroics.
It needs systems that don’t fail.

Standard cleaning protocols are essential, but on their own, they can introduce variability.

That’s why adjunct technologies like UV-C have become so valuable, helping reinforce consistency and reduce reliance on manual processes alone.

When safety depends on workarounds or individual effort, consistency becomes optional, and risk becomes inevitable.

In whole room microbial reduction, that’s where the Power of Three comes in -
three emitters designed for complete room coverage in a single cycle, eliminating the need for multiple placements or repeat cycles.

Less reliance on people.
More confidence in the process.

When it comes to Whole Room Microbial Reduction, dose and validation matter.The FDA has already done the heavy lifting -...
01/15/2026

When it comes to Whole Room Microbial Reduction, dose and validation matter.

The FDA has already done the heavy lifting - establishing criteria for validated Whole Room Microbial Reduction across a patient environment. If a manufacturer has not gone through FDA review and validation, their system is not held to the same standard for delivering a consistent, clinically meaningful UV-C dose on both vertical and horizontal surfaces.

Surfacide’s Helios+ is FDA-Authorized for Whole Room Microbial Reduction and engineered with three emitters to deliver an evidence-based dose throughout the room—walls, equipment, and high-touch surfaces included.

Because when it comes to infection prevention, “almost enough” isn’t enough.

As we welcome 2026, we remain committed to supporting safer environments through trusted UV-C technology and advancing t...
01/01/2026

As we welcome 2026, we remain committed to supporting safer environments through trusted UV-C technology and advancing the standards that help organizations operate with confidence.

Thank you to our partners, customers, and communities for your continued trust. We look forward to the year ahead.

— The Surfacide Team

As the year comes to a close, we’re grateful for the partnerships, trust, and shared commitment to protecting patients, ...
12/25/2025

As the year comes to a close, we’re grateful for the partnerships, trust, and shared commitment to protecting patients, staff, and environments everywhere.

This season is a reminder that supporting safer spaces is a collective effort—one we’re proud to be part of alongside healthcare leaders and teams across the country.

From all of us at Surfacide, we wish you a Merry Christmas and a healthy, peaceful holiday season.

Surfacide is joining infection prevention leaders today at the 17th Annual Infectious Disease Conference in New Jersey!H...
11/12/2025

Surfacide is joining infection prevention leaders today at the 17th Annual Infectious Disease Conference in New Jersey!

Hosted by the Infectious Disease Society of New Jersey and the Northern and Southern Chapters of APIC, this event highlights emerging trends and best practices shaping the future of infection prevention.

Stop by our booth to learn how the FDA Authorized Helios+ UV-C System is setting a new standard for validated, evidence-based disinfection in healthcare environments.

Forsgate Country Club, Monroe Township, NJ
Wednesday, November 12, 2025 | 8:00 a.m. – 3:45 p.m.

+

Address

W226 N918 Northmound Drive Suite 300
Waukesha, WI
53186

Website

Alerts

Be the first to know and let us send you an email when Surfacide posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Establishment

Send a message to Surfacide:

Shortcuts

Share